These findings solidify the mechanistic pathway whereby miRNA-195-5p exerts its tumor-suppressive effects in TNBC by targeting MYB, consequently inhibiting PI3K/AKT/mTOR signaling and cellular proliferation. This evidence concerns the gene AKT1 and neoplasm.